4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Safety and toxicity of nanomaterials for ocular drug delivery applications

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references146

          • Record: found
          • Abstract: not found
          • Article: not found

          New Developments in Liposomal Drug Delivery.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The use of mucoadhesive polymers in ocular drug delivery.

            In the present update on mucoadhesive ocular dosage forms, the tremendous advances in the biochemistry of mucins, the development of new polymers, the use of drug complexes and other technological advances are discussed. This review focusses on recent literature regarding mucoadhesive liquid (viscous solutions, particulate systems), semi-solid (hydrogel, in situ gelling system) and solid dosage forms, with special attention to in vivo studies. Gel-forming minitablets and inserts made of thiomers show an interesting potential for future applications in the treatment of ocular diseases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Niosomes from 80s to present: the state of the art.

              Efficient and safe drug delivery has always been a challenge in medicine. The use of nanotechnology, such as the development of nanocarriers for drug delivery, has received great attention owing to the potential that nanocarriers can theoretically act as "magic bullets" and selectively target affected organs and cells while sparing normal tissues. During the last decades the formulation of surfactant vesicles, as a tool to improve drug delivery, brought an ever increasing interest among the scientists working in the area of drug delivery systems. Niosomes are self assembled vesicular nanocarriers obtained by hydration of synthetic surfactants and appropriate amounts of cholesterol or other amphiphilic molecules. Just like liposomes, niosomes can be unilamellar or multilamellar, are suitable as carriers of both hydrophilic and lipophilic drugs and are able to deliver drugs to the target site. Furthermore, niosomal vesicles, that are usually non-toxic, require less production costs and are stable over a longer period of time in different conditions, so overcoming some drawbacks of liposomes. The niosome properties are specifically dictated by size, shape, and surface chemistry which are able to modify the drug's intrinsic pharmacokinetics and eventual drug targeting to the areas of pathology. This up-to-date review deals with composition, preparation, characterization/evaluation, advantages, disadvantages and application of niosomes.
                Bookmark

                Author and article information

                Journal
                Nanotoxicology
                Nanotoxicology
                Informa UK Limited
                1743-5390
                1743-5404
                August 08 2016
                March 30 2016
                August 08 2016
                : 10
                : 7
                : 836-860
                Affiliations
                [1 ] Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Kingsville, TX, USA;
                [2 ] Department of Medical Physiology, College of Medicine, Texas A&M Health Science Center, Temple, TX, USA;
                [3 ] Department of Surgery and Scott & White Eye Institute, College of Medicine, Texas A&M Health Science Center, Temple, TX, USA
                Article
                10.3109/17435390.2016.1153165
                27027670
                c74385b3-4631-4684-9d69-57d33b295449
                © 2016
                History

                Comments

                Comment on this article